Iovance Biotherapeutics Inc (IOVA)
Healthcare
Biotechnology
4.30 $
+6.0%
vs. previous close
Closing price · As of: 3. Aug 2026
Who owns Iovance Biotherapeutics Inc (IOVA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 86.9% of the shares are freely tradable; institutional investors hold 67.5%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
67.5%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
0.3%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
86.9%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
24.0%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
447Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 6.96 | 31,080,505 | +5.3 | 03/31/2026 |
| Mhr Fund Management Llc | 6.49 | 28,967,103 | +0.0 | 03/31/2026 |
| State Street Corp | 3.91 | 17,448,108 | -13.5 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.72 | 16,617,737 | +0.0 | 03/31/2026 |
| Two Sigma Investments LLC | 3.07 | 13,687,433 | +211.2 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 2.62 | 11,700,844 | +0.0 | 03/31/2026 |
| Millennium Management LLC | 2.11 | 9,414,292 | +43.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| State Street® SPDR® S&P® Biotech ETF | 3.19 | 14,236,316 | -1.0 | 07/30/2026 |
| Vanguard Morn Total Stk Mkt Idx Investor | 3.02 | 13,489,795 | +8.1 | 06/30/2026 |
| iShares Russell 2000 ETF | 2.31 | 10,307,942 | -0.1 | 07/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.